via blogs.wsj.com
“In Sweden, AstraZeneca is one of the most highly-rated companies there, but in the United States the pharmaceuticals industry is rated down at the bottom of the pack because people see pricing, they see direct-to-consumer advertising, and they say ‘it doesn’t seem right that these guys should charge that much money for their drugs and be able to do direct to consumer advertising as well.’”
No comments:
Post a Comment